[nanoPost] Nano-biomaterials for biomedical applications

Company USA

1. Nano-biomaterials for biomedical applications

a. Developed superior nano-biomaterials using innovative materials processing technologies.

b. Focus on the development of the hydroxyapatite (HA) – used extensively as the latest material for the coating of the implants for the human body.

c. The usage of HA synthesized by our process will decrease the failures of the implants, reduce the costs of the insurance and decrease the patient’s trauma.

2. Nanorods

Alternative of the Carbon Nanotubes for the High Volume Applications: The cost of the carbon nanotubes is $100,000 - $200,000 per pound depending on the quality of the nanotubes. At that price, one can’t use it for nanocomposites. In order to provide leap-frog improvement in the strength of nanocomposites and other applications, the company has developed mesoporous nanorods which can provide nanorods of diameter 30-32 nm and of length 100-500 nm.  These nanorods are synthesized by sol-gel chemistry and self-assembly of surfactants methods.  Nanorods of silica, alumina or copper can easily be produced at a cost of $20 a pound.

3. Nano-encapsulated Anticancer Drugs

The company is developing targeted controlled release of the chemotherapeutic agents which is already approved by the FDA for the human trials and was not successful due to the difficulty in maintaining high concentration of such anticancer drug around tumors.

The company’s innovative targeted drug delivery system will allow to maintain high concentration of such drug around tumor to kill tumor. Hence, clinical trials and drug approval can be carried out on the fast track basis. The chemotherapeutic agents have $10 billions per year in the US alone. The world market for such drugs is $20 billions per year.

Access the contact details for this post by subscribing to premium content membership. For more details on premium content membership see our membership and fees page >> or contact info@nanoposts.com, Tel: +44(0)1786 474768.